A
IndiaDescription
Pure-play manufacturer of active pharmaceutical ingredients and intermediates, founded in 2017 and backward integrated from raw materials. Two plants: Jeedimetla, acquired from Mylan in 2018, with 17,201 square metres, five blocks and fifteen clean rooms; and a greenfield site at Kazhipally covering 28,730 square metres. States more than 60 APIs, 122 drug master files and over 30 European certificates.